TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
GENB

Generate Biomedicines, Inc.

Healthcare · Biotechnology

16.50$ -5.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GENB
Line item 2024 2025
100.0% 100.0%
100.0% 100.0%
856.9% 704.5%
205.7% 132.5%
1,062.6% 837.0%
-962.6% -737.0%
10.4% 3.6%
-885.5% -698.6%
1.0% 0.5%
-849.4% -637.0%
-800.2% -653.7%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?